Evaluation of Intra-Abdominal Fat Extraction Using HydraSolve T2D™ in Obese Subjects With Type 2 Diabetes
Recruiting in Palo Alto (17 mi)
Overseen ByRalph DeFronzo, MD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Medality Medical
No Placebo Group
Trial Summary
What is the purpose of this trial?This trial will test a special device to remove specific abdominal fat in obese patients with type 2 diabetes who haven't controlled their blood sugar with pills. The goal is to see if removing this fat helps improve insulin use and lower blood sugar levels.
Eligibility Criteria
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Intra-Abdominal Mesenteric Fat Extraction GroupExperimental Treatment1 Intervention
All enrolled patients will undergo the combined minimally invasive laparoscopic and mini-laparotomy procedure to selectively extract excess intra-abdominal fat from the mesentery.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
University of Texas Health Science Center at San AntonioSan Antonio, TX
Loading ...
Who is running the clinical trial?
Medality MedicalLead Sponsor